ADGM vs GSK · $15.5M cap vs P/E 13, $103.31B cap
Adagio Medical Holdings, Inc Common Stock (ADGM) versus GlaxoSmithKline PLC ADR (GSK) — a side-by-side from cached financials, not a winner call.
Adagio Medical Holdings, Inc Common Stock (ADGM) is a medical devices company listed on NASDAQ.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Latest reported ADGM revenue for 2025-12-31 was $0. Net income was -$25.1M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. ADGM currently screens at market cap $15.5M.
GSK does not have a complete income-statement cache yet.
ADGM currently screens at market cap $15.5M. GSK currently screens at market cap $103.31B and trailing P/E 13.5.
Not investment advice. Open the ADGM and GSK stock pages for the full models.
Not investment advice.